Joensuu H - Search Results

1

Low vs. high radioiodine activity to ablate the thyroid after thyroidectomy for cancer: a randomized study.

Mäenpää HO, Heikkonen J, Vaalavirta L, Tenhunen M, Joensuu H. Mäenpää HO, et al. Among authors: joensuu h. PLoS One. 2008 Apr 2;3(4):e1885. doi: 10.1371/journal.pone.0001885. PLoS One. 2008. PMID: 18382668 Free PMC article. Clinical Trial.

2

Serum VEGF levels in women with a benign breast tumor or breast cancer.

Salven P, Perhoniemi V, Tykkä H, Mäenpää H, Joensuu H. Salven P, et al. Among authors: joensuu h. Breast Cancer Res Treat. 1999 Jan;53(2):161-6. doi: 10.1023/a:1006178517505. Breast Cancer Res Treat. 1999. PMID: 10326793

3

Physical and biological targeting of radiotherapy.

Joensuu H, Tenhunen M. Joensuu H, et al. Acta Oncol. 1999;38 Suppl 13:75-83. doi: 10.1080/028418699432806. Acta Oncol. 1999. PMID: 10612500 Review.

4

Cytochrome P450-inducing antiepileptics increase the clearance of vincristine in patients with brain tumors.

Villikka K, Kivistö KT, Mäenpää H, Joensuu H, Neuvonen PJ. Villikka K, et al. Among authors: joensuu h. Clin Pharmacol Ther. 1999 Dec;66(6):589-93. doi: 10.1053/cp.1999.v66.103403001. Clin Pharmacol Ther. 1999. PMID: 10613614

5

Subclinical cardiotoxicity following adjuvant dose-escalated FEC, high-dose chemotherapy, or CMF in breast cancer.

Erselcan T, Kairemo KJ, Wiklund TA, Hernberg M, Blomqvist CP, Tenhunen M, Bergh J, Joensuu H. Erselcan T, et al. Among authors: joensuu h. Br J Cancer. 2000 Feb;82(4):777-81. doi: 10.1054/bjoc.1999.0998. Br J Cancer. 2000. PMID: 10732745 Free PMC article. Clinical Trial.

6

Serum CD44 levels preceding the diagnosis of non-Hodgkin's lymphoma.

Mäenpää H, Ristamäki R, Virtamo J, Franssila K, Albanes D, Joensuu H. Mäenpää H, et al. Among authors: joensuu h. Leuk Lymphoma. 2000 May;37(5-6):585-92. doi: 10.3109/10428190009058511. Leuk Lymphoma. 2000. PMID: 11042519

7

Interferon alpha-2a therapy in 18 hemangioblastomas.

Niemelä M, Mäenpää H, Salven P, Summanen P, Poussa K, Laatikainen L, Jääskeläinen J, Joensuu H. Niemelä M, et al. Among authors: joensuu h. Clin Cancer Res. 2001 Mar;7(3):510-6. Clin Cancer Res. 2001. PMID: 11297241

8

Late radiation effects in the dog brain: correlation of MRI and histological changes.

Benczik J, Tenhunen M, Snellman M, Joensuu H, Färkkilä M, Joensuu R, Abo Ramadan U, Kallio M, deGritz B, Morris GM, Hopewell JW. Benczik J, et al. Among authors: joensuu h, joensuu r. Radiother Oncol. 2002 Apr;63(1):107-20. doi: 10.1016/s0167-8140(02)00028-2. Radiother Oncol. 2002. PMID: 12065111

9

[Intensity modulated radiotherapy--new technique that will probably improve treatment results].

Joensuu H, Kouri M, Tenhunen M. Joensuu H, et al. Duodecim. 2001;117(4):389-94. Duodecim. 2001. PMID: 12092381 Review. Finnish. No abstract available.

10

Boron neutron capture therapy of brain tumors: clinical trials at the finnish facility using boronophenylalanine.

Joensuu H, Kankaanranta L, Seppälä T, Auterinen I, Kallio M, Kulvik M, Laakso J, Vähätalo J, Kortesniemi M, Kotiluoto P, Serén T, Karila J, Brander A, Järviluoma E, Ryynänen P, Paetau A, Ruokonen I, Minn H, Tenhunen M, Jääskeläinen J, Färkkilä M, Savolainen S. Joensuu H, et al. J Neurooncol. 2003 Mar-Apr;62(1-2):123-34. doi: 10.1007/BF02699939. J Neurooncol. 2003. PMID: 12749708 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

623 results

Search Page

Filters